ClinicalTrials.gov
public full text
Public Domain
MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa
MTBVAC at four dose levels: 5 x 10\^3 CFU, 5 x 10\^4 CFU, 5 x 10\^5 CFU, and 5 x 10\^6 CFU. The active control is BCG (5 x 10\^5 CFU). Participants will receive a single dose of MTBVAC or BCG revaccination administered intradermally on Study Day 0.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate the Pharmacokinetic Profile of CBL-514 Injection in Healthy Volunteers#993005
- BCG vaccination and household TB exposure in childhood tuberculosis: a community-based case-control study in rural Bangladesh.#1147090
- Community-based interventions to improve tuberculosis treatment outcomes: A meta-analysis.#123374
- Community-based interventions to improve tuberculosis treatment outcomes: A meta-analysis.#30913
- Validity and Reliability of the Korean Version of the Supportive Care Needs Scale for Tuberculosis Patients.#988648
Record · ID 909906
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive